BR9813098A - Use of glycosaminoglycans, pharmaceutical preparation, and combination - Google Patents

Use of glycosaminoglycans, pharmaceutical preparation, and combination

Info

Publication number
BR9813098A
BR9813098A BR9813098-6A BR9813098A BR9813098A BR 9813098 A BR9813098 A BR 9813098A BR 9813098 A BR9813098 A BR 9813098A BR 9813098 A BR9813098 A BR 9813098A
Authority
BR
Brazil
Prior art keywords
glycosaminoglycans
combination
pharmaceutical preparation
diabetes
prevention
Prior art date
Application number
BR9813098-6A
Other languages
Portuguese (pt)
Inventor
F J Van Der Woude
Dieter Herr
Volker Laux
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of BR9813098A publication Critical patent/BR9813098A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

"USO DE GLICOSAMINOGLICANS, PREPARAçãO FARMACêUTICA, E, COMBINAçãO" A invenção refere-se ao uso de glicosaminoglicans para a produção de preparações farmacêuticas para a prevenção ou tratamento de doenças dos olhos que são associadas com diabetes. A invenção também se refere à preparações farmacêuticas as quais são adequadas para a prevenção ou tratamento de doenças dos olhos associadas com diabetes."USE OF GLYCOSAMINOGLICANS, PHARMACEUTICAL PREPARATION, AND, COMBINATION" The invention relates to the use of glycosaminoglycans for the production of pharmaceutical preparations for the prevention or treatment of eye diseases that are associated with diabetes. The invention also relates to pharmaceutical preparations which are suitable for the prevention or treatment of eye diseases associated with diabetes.

BR9813098-6A 1997-10-24 1998-10-22 Use of glycosaminoglycans, pharmaceutical preparation, and combination BR9813098A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19747195A DE19747195A1 (en) 1997-10-24 1997-10-24 Compositions for treating diabetic retinopathy
PCT/EP1998/006703 WO1999021538A2 (en) 1997-10-24 1998-10-22 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye

Publications (1)

Publication Number Publication Date
BR9813098A true BR9813098A (en) 2000-08-15

Family

ID=7846613

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813098-6A BR9813098A (en) 1997-10-24 1998-10-22 Use of glycosaminoglycans, pharmaceutical preparation, and combination

Country Status (13)

Country Link
EP (1) EP1047434A2 (en)
JP (1) JP2001520987A (en)
KR (1) KR20010024550A (en)
CN (1) CN1277554A (en)
AU (1) AU749673B2 (en)
BR (1) BR9813098A (en)
CA (1) CA2306379A1 (en)
DE (1) DE19747195A1 (en)
HU (1) HUP0004647A3 (en)
IL (1) IL135171A0 (en)
NO (1) NO20001895D0 (en)
WO (1) WO1999021538A2 (en)
ZA (1) ZA989665B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI991503A1 (en) * 1999-07-08 2001-01-08 Bidifarm S R L USE OF PROTEOGYLICAN OLIGOSACCHARIDIC METABOLITES AS MAKER IN BIOLOGICAL FLUIDS FOR DIAGNOSIS OF BIABET AND PATHOLOGICAL COMPLICATIONS C
CN101584704B (en) * 2008-05-23 2010-12-15 鲁南制药集团股份有限公司 Medicinal application of medicinal salt or derivative of heparin and low molecular heparin
WO2011122321A1 (en) * 2010-03-29 2011-10-06 国立大学法人名古屋大学 Agent for inhibiting physiological activity of heparin-binding protein
CN107137421A (en) * 2017-05-25 2017-09-08 青岛市中心医院 Dextran sulfate is preparing the application in suppressing corneal vascularization medicine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597484B1 (en) * 1986-04-17 1988-12-23 Sanofi Sa GLYCOSAMINOGLYCANS OF THE HEPARIN OR HEPARANE-SULPHATE TYPE WITH ACTIVITY ON CELL DIVISION AND DIFFERENTIATION, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS.
JPH03500168A (en) * 1988-06-27 1991-01-17 ライナー　ローラント Use of glycosaminoglycans for the manufacture of medicines
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
PT93847A (en) * 1989-04-24 1990-11-20 Harvard College PROCESS FOR THE PREPARATION OF OLIGOSACARIDES OF LOW MOLECULAR WEIGHT DERIVED FROM HEPARIN OR DESPOLYMENED HEPARAN SULFATE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
WO1995005182A1 (en) * 1993-08-13 1995-02-23 Glycomed Incorporated Bridged oligosaccharides and sulfated derivatives thereof
WO1995009637A1 (en) * 1993-10-07 1995-04-13 Glycomed Incorporated Highly sulfated maltooligosaccharides with heparin-like properties
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases
AU9160498A (en) * 1997-07-28 1999-02-16 Rijksuniversiteit Leiden Use of sulfated glycosaminoglycans for treating of retinopathy

Also Published As

Publication number Publication date
AU1335599A (en) 1999-05-17
HUP0004647A3 (en) 2002-01-28
WO1999021538A3 (en) 1999-08-05
HUP0004647A2 (en) 2001-05-28
AU749673B2 (en) 2002-07-04
ZA989665B (en) 2000-04-25
WO1999021538A2 (en) 1999-05-06
CN1277554A (en) 2000-12-20
NO20001895L (en) 2000-04-12
NO20001895D0 (en) 2000-04-12
JP2001520987A (en) 2001-11-06
CA2306379A1 (en) 1999-05-06
DE19747195A1 (en) 1999-04-29
KR20010024550A (en) 2001-03-26
IL135171A0 (en) 2001-05-20
EP1047434A2 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
HUP9700603A1 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
BR9713147A (en) Benzamidoaldehyde, use of it, benzamide, and drug preparation for oral, parenteral or intraperitoneal administration.
BG101118A (en) Therapeutical compounds
BR9713704A (en) Keto-benzamide, use of it, and drug preparation
TR199901174T2 (en) New heterocyclylmethyl-substituted pyrazole derivatives.
BR9714517A (en) Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising them and processes to inhibit beta-amyloid peptide release and / or its synthesis by using such compounds
BR0210139A (en) Pharmaceutical Compositions
DK0695171T3 (en) Lyospheres containing gonadotropin
BR9914360A (en) N-aralkylaminotetralins as ligands for neuropeptide receptor yy5
ES2119185T3 (en) TREATMENT OF MICOBACTERIAL DISEASES BY ADMINISTRATION OF BACTERICIDE PROTEIN PRODUCTS / INCREASES PERMEABILITY.
AU7619291A (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
BR9808427A (en) Product, preparation and use process and pharmaceutical composition
ES2173858T3 (en) ANALOGS OF HUPERZINA A.
ES2191449T3 (en) DERIVATIVES OF CICLOPENTABENZOFURANO AND ITS USE.
ES2177024T3 (en) EMPLOYMENT OF THE FANQUINOMA FOR THE TREATMENT OF ALZHEIMER'S DISEASE.
BR9813098A (en) Use of glycosaminoglycans, pharmaceutical preparation, and combination
WO2000072833A3 (en) Pharmaceutical preparations for inhibiting sphingomyelinase
TR199700963T1 (en) Derivative of aminotetral for the treatment of cardiovascular diseases.
AR059965A2 (en) USE OF 8,9-DEHYDROESTRONE FOR THE PREPARATION OF AN ANTIOXIDANT MEDICINAL PRODUCT
GR1002576B (en) Pharmaceutical compositions and a process for the preparation thereof.
PT97052A (en) METHOD FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING BAMBUTEROL, SUITABLE FOR DECREASING THE CONTENT OF BLOOD LIPIDS
ATE241640T1 (en) FUSIDIC ACID DERIVATIVES
BR9710629A (en) Pharmaceutical composition Process for its preparation Compound for use as a therapeutic agent and use and use of a compound
UA32583C2 (en) Derivatives of arylthioalkylthiopyridine
FR2694292B1 (en) Benzimidazole-2-thione- derivatives, their preparation and their use as medicaments.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B25A Requested transfer of rights approved

Free format text: ABBOTT GMBH (DE)

B25D Requested change of name of applicant approved
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.